VYNE Therapeutics
VYNE
#10261
Rank
S$17.27 M
Marketcap
S$0.52
Share price
11.86%
Change (1 day)
-84.96%
Change (1 year)

VYNE Therapeutics (VYNE) - Total debt

Total debt on the balance sheet as of September 2025 : N/A

According to VYNE Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

VYNE Therapeutics - Total debt on balance sheet (from 2018 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$0.13 M-52.39%
2023-12-31S$0.28 M
2022-12-31N/A-100%
2021-12-31S$0.47 M-98.97%
2020-12-31S$46.01 M4776.11%
2019-12-31S$0.94 M
2018-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ORIC Pharmaceuticals
ORIC
S$4.25 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA